Impact of common risk factors of fibrosis progression in chronic hepatitis C.
about
The Elusive Antifibrotic MacrophageAssociation of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver TransplantationDuplex High-Resolution Melting Assay for the Simultaneous Genotyping of IL28B rs12979860 and PNPLA3 rs738409 Polymorphisms in Chronic Hepatitis C PatientsThe PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study.Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.Aging of the Liver: What This Means for Patients with HIV.HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients.Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.Regional challenges: evaluation of a hepatitis outreach programme using transient elastography (FibroScan) in Victoria.TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients.PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.PNPLA3 expression and its impact on the liver: current perspectives.Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model.
P2860
Q26776002-6E883E01-5A55-4188-B693-646EEDF04E24Q35667877-2BB62D24-DB5A-45FE-B2F9-8A9B9C49F080Q36184217-3287AA0F-164F-4AE1-B820-F16D801C3CDCQ36223683-D769EF1F-477F-49DD-A05C-968894DB93FFQ36406176-000F16DE-9650-4556-9E3F-8A66ABBC5D47Q37087800-B8EAEE97-4D86-4005-9CF3-01511448FB7AQ37423627-CC7B45F4-43C5-43E9-872F-BF55FFA23946Q37615221-81ACC47A-3FE2-4005-81E1-78AF5E803B69Q37685491-A324731C-0E3E-4487-9014-4E8BFB4B53FBQ38373475-462C73DD-9CEB-4B10-8CB0-BB94076DEF05Q38936312-B86B13D0-4A23-4663-ACB2-CD23361684DEQ40229182-724FA342-AD57-4249-BA78-966FDBCA583DQ40496274-EFE581EE-CF0F-4E43-B645-057FF6020FA2Q40590610-18C07CCF-F377-4ABC-A994-9E3B6EC76A3FQ40897194-4F3A6C68-9417-441D-933D-D1A227BD7837Q41498105-396EBE3C-E773-4E53-94D1-71F56368112DQ41919708-AF35CD0A-7003-45D0-83C8-45AD4B8F27E7Q42153080-46B558B6-15F8-4827-A18C-CEB34E6D1FB8Q45414078-73A3463E-C1C5-4F65-A114-86F9C0CE2374Q55315556-7118B9B4-AA48-4661-86D2-E6A777CD165A
P2860
Impact of common risk factors of fibrosis progression in chronic hepatitis C.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Impact of common risk factors of fibrosis progression in chronic hepatitis C.
@en
type
label
Impact of common risk factors of fibrosis progression in chronic hepatitis C.
@en
prefLabel
Impact of common risk factors of fibrosis progression in chronic hepatitis C.
@en
P2093
P2860
P50
P1433
P1476
Impact of common risk factors of fibrosis progression in chronic hepatitis C.
@en
P2093
B Müllhaupt
I M Jacobson
J-F Dufour
P2860
P304
P356
10.1136/GUTJNL-2014-306997
P407
P50
P577
2014-09-11T00:00:00Z